111 Inc
NASDAQ:YI
111 Inc
Interest Income Expense
111 Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Interest Income Expense
-¥10.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Interest Income Expense
-¥188.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Interest Income Expense
-¥118.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Interest Income Expense
-¥92.1m
|
CAGR 3-Years
-178%
|
CAGR 5-Years
-92%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Interest Income Expense
-¥41.3m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Interest Income Expense
-¥61.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Interest Income Expense?
Interest Income Expense
-10.7m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Interest Income Expense amounts to -10.7m CNY.
What is 111 Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
18%
Over the last year, the Interest Income Expense growth was 18%.